EMEA-001687-PIP01-14-M06

Key facts

Invented name
Rukobia
Active substance
fostemsavir (tromethamine)
Therapeutic area
Infectious diseases
Decision number
P/0067/2022
PIP number
EMEA-001687-PIP01-14-M06
Pharmaceutical form(s)
Prolonged-release tablet
Condition(s) / indication(s)
Treatment of human immunodeficiency virus (HIV-1) infection
Route(s) of administration
Oral use
Contact for public enquiries
ViiV Healthcare UK Ltd

 +44 (0)7467 443192

eu.paediatric-plans@gsk.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

Related content

How useful was this page?

Add your rating